Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1967 1
1968 2
1969 3
1970 1
1972 1
1973 1
1974 2
1975 1
1978 2
1979 4
1980 5
1981 2
1984 1
1985 1
1987 3
1990 5
1991 3
1992 7
1993 2
1994 6
1995 6
1996 11
1997 10
1998 8
1999 8
2000 9
2001 10
2002 5
2003 9
2004 9
2005 15
2006 6
2007 4
2008 7
2009 25
2010 15
2011 17
2012 13
2013 11
2014 12
2015 18
2016 9
2017 16
2018 29
2019 40
2020 77
2021 77
2022 86
2023 84
2024 68
2025 47

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

756 results

Results by year

Filters applied: . Clear all
Page 1
Prevalence of co-occurring conditions in children and adults with autism spectrum disorder: A systematic review and meta-analysis.
Micai M, Fatta LM, Gila L, Caruso A, Salvitti T, Fulceri F, Ciaramella A, D'Amico R, Del Giovane C, Bertelli M, Romano G, Schünemann HJ, Scattoni ML. Micai M, et al. Among authors: d amico r. Neurosci Biobehav Rev. 2023 Dec;155:105436. doi: 10.1016/j.neubiorev.2023.105436. Epub 2023 Oct 31. Neurosci Biobehav Rev. 2023. PMID: 37913872 Free article.
Hormesis defines the limits of lifespan.
Calabrese EJ, Osakabe N, Di Paola R, Siracusa R, Fusco R, D'Amico R, Impellizzeri D, Cuzzocrea S, Fritsch T, Abdelhameed AS, Wenzel U, Franceschi C, Calabrese V. Calabrese EJ, et al. Among authors: d amico r. Ageing Res Rev. 2023 Nov;91:102074. doi: 10.1016/j.arr.2023.102074. Epub 2023 Sep 13. Ageing Res Rev. 2023. PMID: 37709054 Free article. Review.
Efficacy, safety, and tolerability of switching to long-acting cabotegravir plus rilpivirine versus continuing fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV, 12-month results (SOLAR): a randomised, open-label, phase 3b, non-inferiority trial.
Ramgopal MN, Castagna A, Cazanave C, Diaz-Brito V, Dretler R, Oka S, Osiyemi O, Walmsley S, Sims J, Di Perri G, Sutton K, Sutherland-Phillips D, Berni A, Latham CL, Zhang F, D'Amico R, Pascual Bernáldez M, Van Solingen-Ristea R, Van Eygen V, Patel P, Chounta V, Spreen WR, Garges HP, Smith K, van Wyk J. Ramgopal MN, et al. Among authors: d amico r. Lancet HIV. 2023 Sep;10(9):e566-e577. doi: 10.1016/S2352-3018(23)00136-4. Epub 2023 Aug 8. Lancet HIV. 2023. PMID: 37567205 Clinical Trial.
Selenium for preventing cancer.
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, Zeegers MP, Horneber M, D'Amico R, Crespi CM. Vinceti M, et al. Among authors: d amico r. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4. Cochrane Database Syst Rev. 2018. PMID: 29376219 Free PMC article.
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, D'Amico R, Fyles A, Baron MH, Jürgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Gribaudo S, Provencher D, Hanzen C, Kruitwagen RF, Smit VTHBM, Singh N, Do V, Lissoni A, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL; PORTEC Study Group. de Boer SM, et al. Among authors: d amico r. Lancet Oncol. 2019 Sep;20(9):1273-1285. doi: 10.1016/S1470-2045(19)30395-X. Epub 2019 Jul 22. Lancet Oncol. 2019. PMID: 31345626 Free PMC article. Clinical Trial.
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
Overton ET, Richmond G, Rizzardini G, Thalme A, Girard PM, Wong A, Porteiro N, Swindells S, Reynes J, Noe S, Harrington C, Español CM, Acuipil C, Aksar A, Wang Y, Ford SL, Crauwels H, van Eygen V, Van Solingen-Ristea R, Latham CL, Thiagarajah S, D'Amico R, Smith KY, Vandermeulen K, Spreen WR. Overton ET, et al. Among authors: d amico r. Clin Infect Dis. 2023 May 3;76(9):1646-1654. doi: 10.1093/cid/ciad020. Clin Infect Dis. 2023. PMID: 36660819 Free PMC article. Clinical Trial.
Declaration of Computational Neurosurgery.
Di Ieva A, Suero Molina E, Somerville MA, Beheshti A, Staartjes VE, Serra C, Theodore N, Elliott JM, Wesselink EO, Russo C, Pilitsis JG, Bennett CC, Wu S, Hammond FM, Lozano AM, Cusimano MD, Davidson JM, Castellano JF, Okonkwo DO, Arefan D, Lee CC, Zanier O, Da Mutten R, Matula C, Rutka JT, Pease M, Liu S, Stummer W, Matulionyte R, Yang H, Yuwen C, Cheng X, Fan H, Wang X, Ge Z, Cepeda S, Sheehan JP, Yang JY, Hamer RP, Cohen-Gadol A, Hansford JR, Savage G, Sowman PF, Stewart C, Kateb B, Sherif C, Perperidis A, Guller A, Hanft S, D'Amico RS, Sav A, Cong C, Song Y, Nicolosi F, Wiedmann MKH, Barone DG, Noorani I, Magnussen J, Krieg SM, Meling TR, De Ridder D, Lawton MT, Rosenfeld JV. Di Ieva A, et al. Among authors: d amico rs. Adv Exp Med Biol. 2024;1462:11-20. doi: 10.1007/978-3-031-64892-2_2. Adv Exp Med Biol. 2024. PMID: 39523257
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Orkin C, Schapiro JM, Perno CF, Kuritzkes DR, Patel P, DeMoor R, Dorey D, Wang Y, Han K, Van Eygen V, Crauwels H, Ford SL, Latham CL, St Clair M, Polli JW, Vanveggel S, Vandermeulen K, D'Amico R, Garges HP, Zolopa A, Spreen WR, van Wyk J, Cutrell AG. Orkin C, et al. Among authors: d amico r. Clin Infect Dis. 2023 Nov 17;77(10):1423-1431. doi: 10.1093/cid/ciad370. Clin Infect Dis. 2023. PMID: 37340869 Free PMC article.
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.
Mandrioli J, D'Amico R, Zucchi E, De Biasi S, Banchelli F, Martinelli I, Simonini C, Lo Tartaro D, Vicini R, Fini N, Gianferrari G, Pinti M, Lunetta C, Gerardi F, Tarlarini C, Mazzini L, De Marchi F, Scognamiglio A, Sorarù G, Fortuna A, Lauria G, Bella ED, Caponnetto C, Meo G, Chio A, Calvo A, Cossarizza A. Mandrioli J, et al. Among authors: d amico r. Nat Commun. 2023 Aug 17;14(1):4970. doi: 10.1038/s41467-023-40734-8. Nat Commun. 2023. PMID: 37591957 Free PMC article. Clinical Trial.
Fluorescein-guided resection of gliomas.
Save AV, Gill BJ, D'amico RS, Canoll P, Bruce JN. Save AV, et al. Among authors: d amico rs. J Neurosurg Sci. 2019 Dec;63(6):648-655. doi: 10.23736/S0390-5616.19.04738-6. J Neurosurg Sci. 2019. PMID: 31961117 Review.
756 results